Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

akzo nobel pty limited - cuprous thiocyanate | diuron - antifouling - boat - exterior (antifouling) - fouling - for antifouling on boats

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - tri-allate; liquid hydrocarbon - emulsifiable concentrate - tri-allate carbamate-thiocarbamate active 750.0 g/l; liquid hydrocarbon solvent other 250.0 g/l - herbicide

USA - engelsk - NLM (National Library of Medicine)

mckesson packaging services business unit of mckesson corporation - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 100 mg - major depressive disorder -sertraline hydrochloride tablets are indicated for the treatment of major depressive disorder in adults. the efficacy of sertraline hydrochloride tablets in the treatment of a major depressive episode was established in six to eight week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical trials under clinical pharmacology). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation.  the antidepressant action of sertraline hyd

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

four seasons agribusiness pty ltd - tri-allate; liquid hydrocarbon - emulsifiable concentrate - tri-allate carbamate-thiocarbamate active 500.0 g/l; liquid hydrocarbon solvent other 471.0 g/l - herbicide

USA - engelsk - NLM (National Library of Medicine)

baxter healthcare corporation - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l) - for intramuscular use only (60 mg) rx only carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). ketorolac tromethamine is indicated for the short-term (≤5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. therapy should always be initiated with intravenous or intramuscular dosing of ketorolac tromethamine, and oral ketorolac tromethamine is to be used only as continuation treatment, if necessary. the total combined duration of use of ketorolac tromethamine injection and oral ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see warnings, precautions, dosage and administration, and adverse reactions ). patients should be switched to alternative analgesics as soon as possible, but ketorolac tromethamine therapy is not to exceed 5 days. (see also boxed warning ) ketorolac tromethamine is contraindicated in patients with previously demonstrated hypersensitivity to ketorolac tromethamine. ketorolac tromethamine is contraindicated in patients with active peptic ulcer disease, in patients with recent gastrointestinal bleeding or perforation and in patients with a history of peptic ulcer disease or gastrointestinal bleeding. ketorolac tromethamine should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings – anaphylactoid reactions, and precautions – pre-existing asthma ). ketorolac tromethamine is contraindicated as prophylactic analgesic before any major surgery. ketorolac tromethamine is contraindicated in the setting of coronary artery bypass graft (cabg) surgery (see warnings ). ketorolac tromethamine is contraindicated in patients with advanced renal impairment or in patients at risk for renal failure due to volume depletion (see warnings for correction of volume depletion). ketorolac tromethamine is contraindicated in labor and delivery because, through its prostaglandin synthesis inhibitory effect, it may adversely affect fetal circulation and inhibit uterine musculature, thus increasing the risk of uterine hemorrhage. ketorolac tromethamine inhibits platelet function and is, therefore, contraindicated in patients with suspected or confirmed cerebrovascular bleeding, hemorrhagic diathesis, incomplete hemostasis and those at high risk of bleeding (see warnings and precautions ). ketorolac tromethamine is contraindicated in patients currently receiving aspirin or nsaids because of the cumulative risks of inducing serious nsaid-related adverse events. the concomitant use of ketorolac tromethamine and probenecid is contraindicated. the concomitant use of ketorolac tromethamine and pentoxifylline is contraindicated. ketorolac tromethamine injection is contraindicated for neuraxial (epidural or intrathecal) administration due to its alcohol content.

USA - engelsk - NLM (National Library of Medicine)

puretek corporation - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin is indicated for: gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as gabapentin, during pregnancy. encourage women who are taking gabapentin during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling the toll free number 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org/. risk summary there are no adequate data on the developmental risks associated with the use of gabapentin in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmentally toxic (increased fetal skeletal and visceral abnormalities, and increased embryofetal mortality) when administered to pregnant animals at doses similar to or lower than those used clinically [see data] . in the u.s. general population, the estimated

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - tri-allate; liquid hydrocarbon - emulsifiable concentrate - tri-allate carbamate-thiocarbamate active 625.0 g/l; liquid hydrocarbon solvent other 359.0 g/l - herbicide

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kenso corporation (m) sdn. bhd. - indoxacarb - oil-based suspension concentrates - indoxacarb oxadiazine active 150.0 g/l - insecticide

USA - engelsk - NLM (National Library of Medicine)

c&bcosmetic co., ltd. - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - anti wrinkle [caviall signature bound activator ampoule] provides abundant moisture and nourishment to skin. [caviall superior caviar nourinkle mask] helps to improve skin firming and rejuvenating. [caviall aqua flood water cream] helps to care intensively eye wrinkles and nasolabial fold.

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - omalizumab -